Compare Mesoblast Limited (MESO) vs Noble Corporation plc (NE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Noble Corporation plc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Noble Corporation plc trades at $42.53 (market cap $6.48B). The key difference: Noble Corporation plc is far larger — about 3× Mesoblast Limited's market cap, and Noble Corporation plc pays a 4.93% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | NE | |
|---|---|---|
Market Cap | $2.17B | $6.48B |
Sector | Technology | Technology |
52-Week High | $20.96 | $54.37 |
52-Week Low | $12.88 | $25.70 |
Enterprise Value | $2.17B | $7.73B |
Dividend Yield | — | 4.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
